NantOmics, LLC, a leading player in the biotechnology sector, is headquartered in the United States, with significant operations across various regions. Founded in 2015, the company has rapidly established itself as a pioneer in precision medicine, focusing on the integration of genomic data and advanced analytics to enhance patient care. NantOmics offers a unique suite of products and services, including comprehensive genomic profiling and biomarker discovery, which are designed to support personalised treatment strategies. Their innovative approach sets them apart in the competitive landscape of molecular diagnostics and therapeutics. With a commitment to advancing healthcare through cutting-edge technology, NantOmics has achieved notable milestones, positioning itself as a trusted partner in the fight against complex diseases. The company continues to drive progress in the industry, contributing to the evolution of precision oncology and beyond.
How does NantOmics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
NantOmics, LLC's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NantOmics, LLC, headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. The company has not outlined any reduction targets or climate pledges, which suggests a lack of formal commitments to emissions reduction at this time. It is important to note that NantOmics, LLC is a current subsidiary and may inherit emissions data and climate initiatives from its parent organisation. However, no specific cascading data or targets from a parent company have been provided. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to address climate change. As NantOmics continues to develop its environmental strategy, it may consider aligning with industry standards and frameworks to enhance its climate commitments in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
NantOmics, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
